GlassScriptPhysician profile
Deborah M Neuman
NPI 1417941360
$1,182.16
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $752 · 2020: $313 · 2021: $46.75 · 2022: $42.59 · 2023: $27.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $27.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $27.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $263.61 | 2019 | |
| Glaxosmithkline, LLC. | $144.46 | 2019-2021 | |
| Novo Nordisk INC | $110.35 | 2019-2020 | |
| Astellas Pharma US INC | $101.31 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $73.26 | 2020 | |
| Daiichi Sankyo INC. | $65.46 | 2019-2023 | Injectafer |
| Pfizer INC. | $59.49 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.13 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $54.15 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $49.22 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $37.44 | 2019-2020 | |
| Amgen INC. | $36.60 | 2019 | |
| Janssen Pharmaceuticals, INC | $25.96 | 2019-2020 | |
| Lilly USA, LLC | $19.05 | 2019 | |
| Ethicon US, LLC | $18.71 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $15.13 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.83 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.68 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.37 | 2020 | |
| Sunovion Pharmaceuticals INC. | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Neuman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.